Mindray launches new ultrasound system

AuntMinnie.com staff writers
Feb 14, 2023
2023 02 15 19 52 2104 2023 02 15 Te Air 400

Mindray has introduced its first wireless handheld ultrasound system, the TE Air.

Mindray's TE Air, the company's first wireless handheld ultrasound system. Image courtesy of Mindray.Mindray's TE Air, the company's first wireless handheld ultrasound system. Image courtesy of Mindray.

The system incorporates Mindray's eWave platform and single crystal technology and features exam presets and imaging modes in a wire-free design and compact size. Its air capsule doubles as a protective case and a portable wireless charger; the device takes 35 minutes to charge.

The company's TE Air App is available both for Android and iOS and allows one-handed operation in any location, connecting the device to other systems, such as Mindray's TEX20 Ultrasound, the company said.

Latest in Ultrasound
Baby Bottle
Could cranial ultrasound sub for brain MRI in imaging infants?
November 6, 2024
Images depict a 43-year-old woman with a malignant non-mass lesion that was diagnosed as microinvasive ductal carcinoma. (A) Transverse and (B) longitudinal ultrasound images show a hypoechoic non-mass lesion (solid arrows) with segmental distribution in the left breast. The lesion has associated calcifications (dashed arrows in A). (C) Longitudinal color Doppler ultrasound image shows high vascularity. (D) Magnified image in the mediolateral oblique view from screening mammography shows grouped calcifications (arrows), which are considered a mammographic correlate of the ultrasound-detected non-mass lesion (A radiopaque marker attached to the skin is visible in the image because the mammographic exam was performed after screening breast ultrasound). Ultrasound-guided core needle biopsy and pathologic examination revealed ductal carcinoma in situ, but the lesion was upgraded to microinvasive ductal carcinoma at subsequent surgery (2.5-cm ductal carcinoma in situ, histologic grade II, estrogen receptor-positive, progesterone receptor-positive, human epidermal growth factor receptor type 2-negative).
Ultrasound nonmass breast lesion features may signal malignancy
November 5, 2024
Chat Gpt 400
ChatGPT demonstrates mixed results in assigning BI-RADS categories
November 1, 2024
Ultrasound Breast 400
ABUS screening improves breast cancer screening in low-resource areas
October 29, 2024
Related Stories
Mindray Rsna 2019 400
Ultrasound
Mindray inks strategic agreement with Aegle
2020 01 17 17 06 7024 Mindray Rsna 2019 400
Ultrasound
Mindray highlights ultrasound, 'medical ecosystem' at Arab Health
2021 12 07 21 55 3825 2021 12 07 Mindray 400
Ultrasound
Mindray unveils Resona 7 Lightning Edition
2020 01 17 17 06 7024 Mindray Rsna 2019 400
Ultrasound
Mindray launches new TE7 Max ultrasound scanner
More in Ultrasound
Could cranial ultrasound sub for brain MRI in imaging infants?
By Amerigo Allegretto
Cranial ultrasound could have utility for imaging infants with hypoxic-ischemic encephalopathy.
November 6, 2024
Baby Bottle
Ultrasound nonmass breast lesion features may signal malignancy
By Amerigo Allegretto
Some nonmass breast lesion characteristics on ultrasound exams can be considered suspicious for malignancy at screening ultrasound.
November 5, 2024
Images depict a 43-year-old woman with a malignant non-mass lesion that was diagnosed as microinvasive ductal carcinoma. (A) Transverse and (B) longitudinal ultrasound images show a hypoechoic non-mass lesion (solid arrows) with segmental distribution in the left breast. The lesion has associated calcifications (dashed arrows in A). (C) Longitudinal color Doppler ultrasound image shows high vascularity. (D) Magnified image in the mediolateral oblique view from screening mammography shows grouped calcifications (arrows), which are considered a mammographic correlate of the ultrasound-detected non-mass lesion (A radiopaque marker attached to the skin is visible in the image because the mammographic exam was performed after screening breast ultrasound). Ultrasound-guided core needle biopsy and pathologic examination revealed ductal carcinoma in situ, but the lesion was upgraded to microinvasive ductal carcinoma at subsequent surgery (2.5-cm ductal carcinoma in situ, histologic grade II, estrogen receptor-positive, progesterone receptor-positive, human epidermal growth factor receptor type 2-negative).
ChatGPT demonstrates mixed results in assigning BI-RADS categories
By Amerigo Allegretto
ChatGPT achieves modest accuracy when assigning BI-RADS scores for mammograms and breast ultrasound exams.
November 1, 2024
Chat Gpt 400
ABUS screening improves breast cancer screening in low-resource areas
By Amerigo Allegretto
Automated breast ultrasound (ABUS) with remote reading may improve access to breast cancer screening and early detection in low-resource settings.
October 29, 2024
Ultrasound Breast 400
Ukraine's top pediatric hospital rebuilds after bomb attack
By Philip Ward
Radiology staff at the Ohmatdyt Children's Hospital in Kyiv are making steady progress with their plan to restore normal service after a devastating missile attack.
October 25, 2024
Thanks to the support of the global imaging community, radiology staff at the Ohmatdyt can now look forward to restoring normal service.
CNN models using ultrasound images detect pancreatic neoplasms
By Amerigo Allegretto
A deep-learning method using endoscopic ultrasound images could detect pancreatic neuroendocrine neoplasms.
October 18, 2024
Ultrasound Scanner Computerized 400
Ultrasound method detects cellular rejection in liver transplant cases
By Amerigo Allegretto
An ultrasound measurement technique could detect and stage acute cellular rejection in liver transplant patients.
October 16, 2024
Ultrasound Diagnostic Control Panel
Could elastography replace conventional ultrasound-guided FNAC?
By Amerigo Allegretto
Strain elastography does not have additional benefits over conventional elastography-guided FNAC for diagnosing malignancy in thyroid nodules.
October 15, 2024
Images depict a 43-year-old woman with a solitary left-sided thyroid nodule classified at gray-scale ultrasound as category U3, upgraded to category U4 at strain elastography, and classified as category Thy4 at cytopathologic examination. Subsequent surgical histopathologic examination confirmed papillary cell carcinoma. (A) Longitudinal view of the left thyroid lobe demonstrates the low reflective nodule (between arrows) measuring 13 × 12 × 11 mm (not shown) and with a halo. (B) A longitudinal image with side-by-side visualization of the nodule (arrow) at gray scale (left) and strain elastography (right). The nodule is predominantly blue, indicating increased stiffness. (C) A longitudinal view shows the needle (arrows) within the stiffer aspect of the nodule for cytology sampling. U and Thy categories are according to British Thyroid Association system. Image courtesy of the RSNA.
Ultrasound test detects 96% of ovarian cancers
By Kate Madden Yee
An ultrasound test can identify 96% of ovarian cancers in postmenopausal women, researchers have reported.
October 1, 2024
Ovarian Cancer
Publicly insured pregnant women less likely to get 20-week ultrasounds
By Amerigo Allegretto
Twenty-week ultrasound exams for pregnant women drives disparities in prenatal diagnosis of congenital heart defects.
September 23, 2024
Fetal Ultrasound
Lung ultrasound underdiagnoses pneumothorax in trauma patients
By Amerigo Allegretto
Lung ultrasound underdiagnoses clinically significant pneumothorax on initial trauma evaluation.
September 20, 2024
Ultrasound Probe Vascular
Dedicated ultrasound, MRI protocols improve endometriosis diagnosis
By Kate Madden Yee
Dedicated ultrasound and MRI protocols -- in contrast to routine ones -- are more effective in diagnosing endometriosis, researchers have reported.
September 13, 2024
Ultrasound Transducer3
Page 1 of 512
Next Page